share_log

HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $9 Price Target

Benzinga ·  Aug 14 07:00  · Ratings

HC Wainwright & Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $9 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment